Organophotocatalytic late-stage N-CH3 oxidation of trialkylamines with O2 in continuous flow

Mark John P. Mandigma, Jonas Žurauskas, Callum I. MacGregor, Lee J. Edwards, Ahmed Shahin, Ludwig d’Heureusea, Philip Yip, David J. S. Birch, Thomas Gruber, Jörg Heilmann, Matthew P. John, Joshua P. Barham

Research output: Working paper

57 Downloads (Pure)

Abstract

We report an organophotocatalytic, N-CH3-selective oxidation of trialkylamines in continuous flow. Based on the 9,10-dicyanoanthracene (DCA) core, a new catalyst (DCAS) was designed with solubilizing groups for processing in flow which allowed harnessing of O2 as a benign reagent for late-stage photocatalytic N-CH3 oxidation of natural products and active pharmaceutical ingredients. These substrates bear functional groups which are not tolerated by previous methods. The organophotocatalytic process benefited from the flow
parameters, affording cleaner reactions in short residence time of 13.5 mins and productivities of up to 0.65 g / day. Mechanistic studies found that catalyst derivatization not only enhanced solubility of the new catalyst compared to DCA, it profoundly diverted the photocatalytic reaction mechanism from singlet
electron transfer (SET) reductive quenching with amines to energy transfer (EnT) with O2.
Original languageEnglish
Place of PublicationCambridge, UK
Number of pages10
DOIs
Publication statusPublished - 20 Sept 2021

Keywords

  • medicinal chemistry
  • diversity-oriented synthesis
  • bioactive molecules

Fingerprint

Dive into the research topics of 'Organophotocatalytic late-stage N-CH3 oxidation of trialkylamines with O2 in continuous flow'. Together they form a unique fingerprint.

Cite this